Mayabeque, Cuba_ The Bio CubaFarma Business Group has two pillars of great importance in the fulfillment of the Cuban strategy in biotechnology in two scientific institutions of this province, both of which are about to complete a successful year 2018 with a high productive and value contribution.

The National Center for the Production of Laboratory Animals (CENPALAB) and the National Center for Biopreparations (BIOCEN), both located in the municipality of Bejucal, produce, research and develop high-level products and proposals in Cuba and beyond our borders.

The human and veterinary vaccines, bio-products, drugs, diagnostic tools and monoclonal antibodies created by Cuba, place our country, along with India and Brazil, at the forefront of the Third World as the nations with the most advances in this sector.

Specifically BIOCEN elaborates Culture Media, Active Ingredients and Parenteral Products that are used in the main products of BioCubaFarma: Heberprot-p, the best treatment for diabetic foot ulcers, Cimavax-EGF vaccine, a hope against lung cancer, the Policosanol (ppg), a natural product to lower cholesterol, Va-Mengoc-bc, very effective vaccine against meningococcus B and C and Neuroepo, a medicine that delays the progression of Alzheimer's.

This Business Group, one of the most economically powerful in Cuba, is in charge of directing the biotechnological and pharmaceutical industries. It has registered products and exports to 43 countries. Its annual income exceeds 3 billion dollars, according to the most recent official figures.

Compartir / Share